Research
Association between diagnosis to treatment interval and survival outcomes in diffuse large B-cell lymphoma using a causal inference approach
Nature ·
The Brief
- A study published in Scientific Reports examines the association between diagnosis-to-treatment interval and survival outcomes in diffuse large B-cell lymphoma.
- The analysis uses a causal inference approach.
- The source feed provided no summary, so further quantitative findings are not available from the sources given.
Why it matters
Waiting time from diagnosis to treatment is a modifiable factor in cancer care, so a causal analysis of its link to survival in a common lymphoma can inform clinical and health-system timing decisions.
Who’s affected
- clinicians and oncology teams treating diffuse large B-cell lymphoma
- health policy researchers studying cancer treatment delays